KCT0000355招募中未知
Prevention of Cardiovascular events in ischemic stroke patients with high risk of cerebral hemorrhage: PICASSO study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 40(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •patinets having high-risk of cerebral hemorrage proved by past history of cerebral hemorrhage or multiple microbleeds on MRI among acute stroke patients who were admitted in 4 hostpitals
排除标准
- •acute stroke patients with cardioembolic source or
- •patients within 6 months of life expectancy
研究者
相似试验
已完成
不适用
Improving the prevention of vascular events after stroke or transient ischemic attackStrokeISRCTN63816609Royal Devon and Exeter Foundation Trust (UK)30
进行中（未招募）
1 期
Can the heart drug enalapril prevent heart damage in patients with newly diagnosed breast cancer and lymphoma receiving chemotherapy?Prevention of cardiotoxicityMedDRA version: 20.0Level: PTClassification code 10048610Term: CardiotoxicitySystem Organ Class: 10007541 - Cardiac disordersEUCTR2017-001094-16-GBSouth Tees NHS Foundation Trust170
已完成
不适用
Secondary Prevention of Adverse Cardiovascular Events in Cases with Anomalous Origins of Coronary Arteries: Clinical Features, Management, and Long-Term OutcomeAnomalous Origin of the Coronary ArteryJPRN-UMIN000030629ihon University60
进行中（未招募）
不适用
Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack.The PERFORM Study.An international, randomised, double-blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg o.d. administered orally for a 3-year mean duration (event driven trial). - PERFORMIschaemic stroke or transient ischaemic attackMedDRA version: 7.0Level: PTClassification code 10008190EUCTR2005-003700-10-BEInstitut de Recherches Internationales Servier18,000
进行中（未招募）
不适用
Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack.The PERFORM Study.An international, randomised, double-blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg o.d. administered orally for a 3-year mean duration (event driven trial). - PERFORMEUCTR2005-003700-10-LTInstitut de Recherches Internationales Servier18,000